The effects of dexmedetomidine on human neutrophil apoptosis

Biomedical Research

Volumn 29, Issue 4, 2008, Pages 189-194

  Kishikawa, Hiroaki ^a   Kobayashi, Katsuya ^a   Takemori, Ken ^a   Okabe, Tadashi ^a   Ito, Kimiaki ^a   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; DEXMEDETOMIDINE; HOE 33342; SUPEROXIDE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT; YOHIMBINE;

APOPTOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTENSIVE CARE UNIT; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUTROPHIL; NORMAL HUMAN; SEDATION; CELL MEMBRANE POTENTIAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; MALE; METABOLISM; PHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; APOPTOSIS; CASPASES; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MEMBRANE POTENTIALS; NEUTROPHILS; SUPEROXIDES; YOHIMBINE;

EID: 53149138212     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.29.189     Document Type: Article

References (20)

1. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM and Treacher DF (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157-169.
2. Chen Y, Zhao 4 Code WE and Hertz L (2000) A correction between dexmedetomidine-induced biphasic increases in free cytosolic calcium concentration and energy metabolism in astrocytes. Anesth Analg 91, 353-357.
3. Cupić V, Colić M, Pavicić L, Vucelvić D and Varagić VM (2001) Immunomodulatory effect of xylazine, an alpha (2) adrenergic agonist, on rat spleen cells in culture. J Neuroimmunol 113, 19-29.
4. Earnshaw WC, Martins LM and Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68, 383-424.
5. Fanning NF, Porter J, Shorten GD, Kirwan WO, Bouchier-Hayes D, Cotter TG and Redmond HP (1999) Inhibition of neutrophil apoptosis after elective surgery. Surgery 126, 527-534.
6. Fossati G, Modulding, DA, Spiller DG, Moots RJ, White MR and Edwards SW (2003) The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol 170, 1964-1972.
7. Heine J, Leuwer M, Scheinichen D, Arseniev L, Jaeger K and Piepenbrock S (1996) Flow cytometry evaluation of the in vitro influence of four i.v. anaesthetics on respiratory burst of neutrophils. Br J Anaesth 77, 387-392.
8. Khan ZP, Ferguson CN and Jones RM (1999) Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54, 146-165.
9. Lee A, Whyte MK and Haslett C (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54, 283-288.
10. Liu D, Li C, Chen Y, Burnett C, Liu XY, Downs S, Collins RD and Hawigner J (2004) Nuclear import of proinflammatory transcription factors is required for massive liver, apoptosis induced by bacterial lipopolysaccharide. J Biol Chem 279, 48434-48442.
11. Matsuda T, Saito H, Fukatsu K, Han I, Inoue T, Furukawa S, Ikebe S and Hidemura A (2001) Cytokine-modulated inhibition of neutrophil apoptosis at local site augments exudative neutropbil finictions and reflects inflammatory response after surgery. Surgery 129, 76-85.
12. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H and Niwa Y (1999) The effects of clonidine and dexmedetomidine on human neutrophill functions. Anesth Analg 88, 452-458.
13. Panosian JO and Marinetti GV (1983) Alpha 2-adrenergic receptors in human polymorphonuclear leukocyte membranes. Biochem Pharmacol 32, 2243-2247.
14. Pithon-Curi TC, Schumacher RI, Freitas JJ, Lagranha C, Newsholme P, Palanch AC, Doi SQ and Curi R (2003) Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol 284, C1355-C1361.
15. Scheel Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM., Assi LK, Parkes N, Clough LE, Gulbins E, Salmon M and Lord JM (2004) Reactive oxygen species limit neutrophil life spp by activating death receptor signaling. Blood 104, 2557-2564.
16. Tan AS, and Berridge MV (2000) Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazon: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods 238, 59-68.
17. Utsumi T, Klostergaard J, Akimaru K, Edashige K, Sato EF and Utsumi K (1992) Modulation of TNF-alpha-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors. Arch Biochem Biophys 294, 271-278.
18. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM and Grounds RM (1999) Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54, 1136-1142.
19. Watson RW, O'Neil A, Brannigan AE, Coffey R, Marshall JC, Brady HR and Fitzpatrick JM (1999) Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent. FEBS Lett 453, 67-71.
20. Whyte MK, Meagher LC, MacDermot J and Haslett C (1993) Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 150, 5124-5134.